First-line Systemic Therapy Following Adjuvant Immunotherapy in Renal Cell Carcinoma: An International Multicenter Study
Talal El Zarif, Karl Semaan, Wanling Xie, Marc Eid, Martín Zarbá, Wadih Issa, Tian Zhang, Charles B. Nguyen, Ajjai Alva, Catherine C. Fahey, Kathryn E. Beckermann, José A. Karam, Matthew T. Campbell, Giuseppe Procopio, Marco Stellato, Sebastiano Buti, Anežka Zemánková, Bohuslav Melichar, Francesco Massari, Veronica Mollica, Balaji Venugopal, Hedyeh Ebrahimi, Guillermo de Velasco, Howard Gurney, Ugo De Giorgi, Omi Parikh, Eric Winquist, Viraj A. Master, Abraham Ruiz Garcia, Hernan Javier Cutuli, Thomas Ferguson, Marine Gross‐Goupil, Sylvan C. Baca, Sumanta K. Pal, David A. Braun, Rana R. McKay, Daniel Yick Chin Heng, Toni K. Choueiri
Topics & Concepts
MedicineRenal cell carcinomaPembrolizumabAdjuvantOncologySystemic therapyImmunotherapyInternal medicineAdjuvant therapyCarcinomaKidney cancerChemotherapyCancerBreast cancerRenal cell carcinoma treatmentCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis